15-Jun-2021 - Ruhr-Universität Bochum (RUB)

What happens in brain cells affected by Alzheimer’s disease?

Studies on tissue from patients and mini-brains made from stem cells shed light on the disease

In addition to plaques that accumulate outside of nerve cells in the brain, Alzheimer’s disease is also characterised by changes inside these cells. Researchers from the Cell Signalling research group at the Chair of Molecular Biochemistry at RUB, headed by Dr. Thorsten Müller, have been studying what exactly happens in these cells. They determined that various proteins and protein components accumulate in the cells, which also affect their functions. Moreover, they identified a correlation between the progression of the disease and certain corpuscles in the cell nuclei.

Aggregates seem to have a function

Affecting over 50 million people, Alzheimer’s disease is the most common form of dementia and primarily occurs in people over the age of 65. The pathology of the disease in the brain is mainly characterised by two factors: beta-amyloid plaques outside the nerve cells and tau proteins. The tau protein stabilises tube-like structures (microtubules) inside cells, which are relevant for the transport of nutrients in nerve cells. Beta-amyloid is a protein present in the body that is formed by the cleavage of the amyloid precursor protein (APP).

APP is embedded in the cell membrane of the nerve cells and protrudes both on the inside and outside. Typically, it is cleaved once near the cell membrane The part inside the nerve cells is unstable and disintegrates. In Alzheimer’s patients, two cleavages take place, resulting in the formation of three parts. The new findings now indicate that the part inside the nerve cells is more stable in Alzheimer’s patients. It consists of only approximately 50 amino acids and can, under certain conditions, migrate into the cell nucleus together with other proteins such as FE65 and TIP60. This protein complex, also known as nuclear aggregates, has the capacity to manipulate the cell’s gene expression. “This suggests that the aggregates have a function in this region,” points out lead author David Marks from the Cell Signaling group at RUB. Closer analysis confirmed this evidence, as a protein was found within the nuclear aggregates that is involved in the modification of DNA.

Two more protein candidates in cells

“To understand this mechanism even better, we looked for other proteins that might be part of these aggregates and identified two more candidates involved in the nuclear aggregates, the so-called tumour suppressor proteins P53 and PML,” explains David Marks. The study team showed in experiments on living cells that nuclear aggregates formed from the proteins APP-CT50, FE65, TIP60 and PML fuse with each other over time and produce even larger nuclear aggregates.

In addition, they examined brain samples from older deceased persons as well as self-generated neuronal tissue from induced pluripotent stem cells. “These mini-brains, so-called cerebral organoids, reflect the embryonic and developmental phase of a brain fairly accurately,” explains Thorsten Müller. The research team found nearly no nuclear aggregates in the comparatively young cerebral organoids, whereas they were present in brain samples from older patients. “This leads us to conclude that the process depends on age,” says Müller.

Striking correlation

Furthermore, the researchers showed on these brain samples that APP-CT50 and FE65 can make up part of the so-called PML bodies, which occur naturally in large numbers of cell nuclei. Upon further analysis of hippocampal brain slices from Alzheimer’s patients, the authors identified a significant correlation between a reduced number of PML bodies in the nucleus in regions with a high beta-amyloid plaque load. In particular, such regions mean that there is higher expression and processing of APP. This may suggest that the transfer of APP-CT50 and FE65 into the nucleus is part of AD pathology and affects the fusion of PML bodies there.

Facts, background information, dossiers

  • nerve cells
  • brain cells
  • Alzheimer's disease
  • brain
  • dementia

More about Ruhr-Universität Bochum

  • News

    The role of hydrophobic molecules in catalytic reactions

    Electrochemical processes could be used to convert CO2 into useful starting materials for industry. To optimise the processes, chemists are attempting to calculate in detail the energy costs caused by the various reaction partners and steps. Researchers from Ruhr-Universität Bochum (RUB) an ... more

    A stable copper catalyst for CO2 conversion

    A new catalyst for the conversion of carbon dioxide (CO2) into chemicals or fuels has been developed by researchers at Ruhr-Universität Bochum and the University of Duisburg-Essen. They optimized already available copper catalysts to improve their selectivity and long-term stability. The re ... more

    Quickly identify high-performance multi-element catalysts

    Finding the best material composition among thousands of possibilities is like looking for a needle in a haystack. An international team is combining computer simulations and high-throughput experiments to do this. Catalysts consisting of at least five chemical elements could be the key to ... more

  • q&more articles

    Customized ligands pave the way for new reaction pathways

    For the first time, an efficient catalyst for palladium-catalyzed C–C bonding between aryl chlorides and alkyl lithium compounds has been found. This reaction enables simpler synthesis routes for important products, such as pharmaceuticals, while avoiding much salt waste. more

    Light plus current: The formula for researching what happens to individual nanoparticles

    A combination of dark-field microscopy and electrochemistry can make individual nanoparticles in a liquid medium visible. The technique is suited to determine the activity of catalysts during their use. more

    Vibrational spectroscopy - Label-free imaging

    Spectroscopic methods are now granting us deep insights into biological systems at previously unattainable spatial and temporal resolutions. Complementing the already well-established fluorescence spectroscopy, the major potential of label-free vibrational spectroscopy has become clear in r ... more

  • Authors

    Henning Steinert

    Henning Steinert, born in 1993, studied chemistry at Carl-von-Ossietzky University in Oldenburg, where he researched, among other things, the activation of Si–H bonds on titanium complexes. He is currently working on his doctorate at the Ruhr-Universität Bochum, Chair of Inorganic Chemistry ... more

    Prof. Dr. Viktoria Däschlein-Gessner

    Viktoria Däschlein-Gessner, born in 1982, studied chemistry at Marburg and Würzburg universities and received her doctorate from the Technical University Dortmund in 2009. After a postdoctoral stay at the University of California in Berkeley, she headed an Emmy Noether junior research group ... more

    Kevin Wonner

    Kevin Wonner, born in 1995, studied chemistry with the focus on electrochemical nanoparticle characterization at the Ruhr University Bochum. He started his PhD in 2018 at the chair of Analytical Chemistry II of Professor Dr. Kristina Tschulik and is supported by the graduate school 2376. Hi ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: